The state of Texas currently has 82 active clinical trials seeking participants for Pain research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery
Recruiting
The goal of this clinical trial is to evaluate the efficacy and safety of OCS-01 in treating inflammation and pain in subjects following cataract surgery.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/09/2024
Locations: Oculis Investigative Site, Austin, Texas +2 locations
Conditions: Inflammation Eye, Pain, Postoperative, Cataract
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Recruiting
The REALITY study is a prospective, post-market, non-randomized, multi-center, single-arm, open-label study intended to collect short- and long-term safety and effectiveness data on various populations implanted with Abbott's neurostimulation systems.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/08/2024
Locations: Expert Pain, Houston, Texas +3 locations
Conditions: Chronic Pain
Heating Pad for in Office Cystoscopy and Urodynamic Testing
Recruiting
Patient frequently report experiencing discomfort associated with cystoscopy or urodynamic studies (UDS), and a small percentage of patients refuse these important procedures due to discomfort or fear of discomfort. Heating pads are an inexpensive and low-risk way to reduce patient discomfort during these procedures, which to our knowledge has not been investigated in the United States.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/04/2024
Locations: University of Texas Health Science Center at San Antonio, San Antonio, Texas
Conditions: Anxiety, Pain, Distress, Emotional
MDR - PMCF Study for Taperloc Complete Stems
Recruiting
The objective of this consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Taperloc Complete stems when used for primary or revision total hip arthroplasty (implants) at 1,3,5,7 and 10-year follow-up*. Since Taperloc Complete was introduced to the EU in 2010, all available retrospective data will be collected from each patient and a prospective aspect to the study will be necessary to reach the 10-year time point.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/12/2023
Locations: Texas Health Physicians Group, Plano, Texas
Conditions: Hip Arthritis, Hip Disease, Hip Fractures, Hip Injuries, Hip Pain Chronic
XG005 for Pain Control in Subjects Undergoing Bunionectomy
Recruiting
This study will evaluate the safety, efficacy, and PK of low dose (750 mg) and high-dose (1250 mg) XG005 oral tablets compared with placebo in subjects undergoing bunionectomy. Subjects will be confined in the clinic from check-in through 72 hours post-surgery to monitor subject safety.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
12/08/2023
Locations: First Surgical Hospital, Bellaire, Texas +3 locations
Conditions: Acute Pain
A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain
Recruiting
This is a multicenter randomized, double-blind, placebo-controlled phase 2 study to evaluate efficacy, safety, tolerability, pharmacokinetics, and target engagement of GSK3858279 in adult participants with chronic Diabetic Peripheral Neuropathic Pain (DPNP). The primary objective of the study is to assess the efficacy of GSK3858279 in participants with DPNP who have been unable to sufficiently manage their pain.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
12/05/2023
Locations: GSK Investigational Site, Houston, Texas +2 locations
Conditions: Pain
Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
Recruiting
This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated topical application of Qutenza (capsaicin 8% topical system) versus low-dose capsaicin control (capsaicin 0.04% topical system) in subjects with moderate to severe postsurgical neuropathic pain (PSNP).
Gender:
All
Ages:
18 years and above
Trial Updated:
12/05/2023
Locations: Expert Pain, Houston, Texas +1 locations
Conditions: Post Surgical Neuropathic Pain
A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 2)
Recruiting
The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb amputation.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
12/04/2023
Locations: The University of Texas Health Science Center, Houston, Texas
Conditions: Pain Management
A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1)
Recruiting
The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb amputation.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
12/04/2023
Locations: The University of Texas Health Science Center, Houston, Texas
Conditions: Pain Management
A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 3)
Recruiting
The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb amputation after multiple sessions of treatment.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
12/04/2023
Locations: The University of Texas Health Science Center, Houston, Texas
Conditions: Pain Management
Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience
Recruiting
The first objective of the study is to evaluate whether a novel bio-signature (derived from a wide range of pro- and anti-nociceptive IL-1 family cytokine activity) will predict pain experienced and also release of underlying endogenous opioid neurotransmitters during an experimental nociceptive pain challenge, which will be performed while simultaneously quantifying mu-opioid receptor activity in the brain via [11C]-carfentanil PET neuroimaging in healthy subjects. Another objective is to evalu... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
12/01/2023
Locations: The University of Texas Health Science Center at Houston, Houston, Texas
Conditions: Pain
A Pilot Study Assessing the Effectiveness of Use of Guided Imagery for Treatment of Pain and Symptom Management in Women With Post-mastectomy Pain Syndrome
Recruiting
To learn if using guided imagery and deep breathing techniques can help with pain management in patients who have post-mastectomy pain syndrome.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/28/2023
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Pain Syndrome, Pain, Symptom Management